Plasma Marker Predicts Allograft Failure in Lung Transplant

Share this content:
Plasma Marker Predicts Allograft Failure in Lung Transplant
Plasma Marker Predicts Allograft Failure in Lung Transplant

THURSDAY, Jan. 24, 2019 (HealthDay News) -- Donor-derived cell-free DNA (ddcfDNA) is a potential biomarker that can predict allograft failure after lung transplantation, according to a study published online Jan. 23 in EBioMedicine.

Sean Agbor-Enoh, M.D., Ph.D., from the Genomic Research Alliance for Transplantation in Bethesda, Maryland, and colleagues used percent ddcfDNA as a sensitive marker of early graft injury to predict allograft failure in 106 patients who underwent lung transplantation. Participants were monitored for development of allograft failure. In the first three months after transplantation, plasma samples were collected and assayed for percent ddcfDNA. The average levels of percent ddcfDNA (avddDNA) were computed over three months, and the correlation with allograft failure was assessed.

The researchers found that the avddDNA was highly variable, with median values of 3.6, 1.6, and 0.7 percent for the upper, middle, and low tertiles, respectively. Participants with avddDNA in the upper tertile had a 6.6-fold higher risk for developing allograft failure compared with those in the low and middle tertiles; they also had lower peak forced expiratory volume in one-second values and more frequent percent ddcfDNA elevations that were not clinically detectable.

"In summary, from our proof-of-concept study, we propose avddDNA as a predictive marker for allograft failure and premature death," the authors write. "To our knowledge, this is the first report of a method to detect and quantify clinically silent, but likely pathological, events preceding allograft failure."

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Progress in HIV Prevention Has Stalled in the United States

CDC: Progress in HIV Prevention Has Stalled in ...

Agency says effective HIV prevention, treatment not reaching those who could most benefit

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in Children

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in ...

All children with sustained unresponsiveness ingested concentrated and baked egg

Prenatal Vitamin Intake in Early Pregnancy May Cut Autism Risk

Prenatal Vitamin Intake in Early Pregnancy May Cut ...

ASD risk down for children whose mothers took prenatal vitamins during first month of pregnancy

is free, fast, and customized just for you!




Already a member?

Sign In Now »